close
relat
anoth
zoonot
viru
hendra
viru
nipah
hendra
member
viru
famili
paramyxovirida
nipah
viru
caus
focal
outbreak
howev
capabl
caus
signific
mortal
human
made
emerg
viral
infect
public
heath
concern
malaysian
outbreak
total
peopl
infect
die
singapor
outbreak
led
case
death
risk
transmiss
nipah
viru
sick
anim
human
thought
low
persontoperson
transmiss
document
yet
even
context
larg
outbreak
malaysia
singapor
outbreak
patient
direct
contact
pig
mode
transmiss
anim
anim
anim
human
uncertain
seem
requir
close
contact
contamin
tissu
bodi
fluid
infect
anim
believ
certain
speci
fruit
bat
natur
host
nipah
viru
bat
seem
suscept
infect
viru
becom
ill
unknown
viru
transmit
bat
anim
role
speci
pig
transmit
infect
anim
yet
determin
incub
period
diseas
day
infect
may
mild
subclin
symptomat
case
onset
usual
influenzalik
symptom
high
fever
myalgia
diseas
may
progress
enceph
drowsi
disorient
convuls
coma
procedur
laboratori
diagnosi
nipah
viru
infect
includ
serolog
histopatholog
immunohistochemistri
electron
microscopi
polymeras
chain
reaction
pcr
viru
isol
drug
therapi
prove
effect
treat
nipah
infect
treatment
reli
provid
intens
support
care
evid
treatment
antivir
drug
ribavirin
may
reduc
mortal
acut
nipah
enceph
phenol
disinfect
effect
paramyxovirus
polar
lipophil
solvent
chloroform
effect
hantavirus
serolog
relat
member
famili
bunyavirida
term
hantaviru
deriv
hantaan
river
prototyp
old
world
hantaviru
hantaan
viru
first
isol
diseas
associ
old
world
hantaan
viru
call
korean
hemorrhag
fever
hemorrhag
fever
renal
syndrom
region
especi
affect
hemorrhag
fever
renal
syndrom
includ
china
korean
peninsula
russia
hantaan
seoul
virus
northern
western
europ
puumala
dobrava
virus
newli
recogn
speci
hantaviru
new
world
hantaviru
found
caus
hantaviru
pulmonari
syndrom
southwestern
unit
state
hantaviru
pulmonari
syndrom
subsequ
recogn
throughout
contigu
unit
state
america
june
total
case
hantaviru
pulmonari
syndrom
identifi
state
casefat
rate
sever
hantavirus
pathogen
human
identifi
unit
state
includ
new
york
viru
black
creek
canal
viru
bayou
viru
hantavirus
rodentborn
arthropod
vector
implic
transmiss
hantavirus
caus
overt
ill
reservoir
host
transmiss
human
believ
via
aerosol
infect
excreta
rodent
persontoperson
transmiss
report
old
world
hantaviru
unit
state
hantavirus
known
caus
hantaviru
pulmonari
syndrom
carri
new
world
rat
mice
famili
murida
subfamili
sigmodontina
hemorrhag
fever
renal
syndrom
character
fever
myalgia
develop
day
week
incub
period
day
exposur
rodent
diseas
progress
hemorrhag
hemodynam
instabl
occasion
progress
shock
diseas
enter
second
phase
affect
kidney
character
first
oliguria
polyuria
hypertens
bleed
mucou
membran
edema
lung
mortal
usual
shock
hemorrhag
fatal
rate
puumala
viru
hantaan
viru
dobrava
viru
hantaviru
pulmonari
syndrom
character
fever
chill
sever
myalgia
progress
variabl
sever
respiratori
compromis
hemodynam
instabl
thrombocytopenia
common
hemoconcentr
hematolog
abnorm
occur
commonli
sever
case
diagnosi
hantavirus
base
histori
possibl
contact
rodent
clinic
find
serolog
result
earli
phase
ill
infect
differenti
viral
fever
direct
detect
antigen
earli
diagnosi
diseas
also
use
viru
antigen
shown
blood
urin
isol
viru
urin
success
earli
ill
wherea
isol
viru
blood
less
consist
ribavirin
effect
hantaan
viru
made
avail
postexposur
prophylaxi
soldier
oper
desert
shieldstorm
support
care
dialysi
support
kidney
mainten
blood
volum
also
import
virus
kill
sodium
hypochlorit
glutaraldehyd
ethanol
yellow
fever
viral
hemorrhag
fever
transmit
infect
mosquito
infect
caus
wide
spectrum
diseas
mild
symptom
sever
ill
death
yellow
name
stand
jaundic
affect
patient
yellow
fever
occur
africa
south
america
world
health
organ
estim
case
yellow
fever
occur
year
sylvat
jungl
intermedi
urban
three
cycl
infect
yellow
fever
viru
jungl
yellow
fever
diseas
monkey
rare
diseas
occur
mainli
individu
expos
tropic
rain
forest
bitten
mosquito
infect
monkey
intermedi
cycl
yellow
fever
occur
humid
semihumid
savannah
africa
smallscal
epidem
rural
area
semidomest
mosquito
infect
monkey
human
host
urban
yellow
fever
diseas
human
spread
aed
aegypti
mosquito
infect
peopl
mosquito
adapt
live
among
human
citi
town
villag
urban
yellow
fever
caus
yellow
fever
outbreak
epidem
mosquito
take
blood
meal
infect
monkey
human
urban
bite
human
inject
saliva
contain
viru
bite
prevent
blood
clot
infect
human
clinic
spectrum
yellow
fever
rang
subclin
infect
overwhelm
multisystem
diseas
symptom
occur
day
infect
usual
includ
fever
prostrat
headach
photophobia
lumbosacr
pain
extrem
pain
includ
knee
joint
epigastr
pain
anorexia
vomit
second
phase
involv
liver
kidney
hemorrhag
symptom
sign
caus
thrombocytopenia
abnorm
coagul
occur
fatal
rate
sever
yellow
fever
approxim
definit
diagnosi
made
viral
cultur
blood
tissu
specimen
also
made
identif
yellow
fever
viru
antigen
nucleic
acid
tissu
use
immunohistochemistri
enzymelink
immunosorb
assay
elisa
pcr
test
detect
igm
antibodi
captur
elisa
confirm
fourfold
greater
increas
neutral
antibodi
titer
acutephas
convalescentphas
serum
sampl
also
diagnost
live
attenu
viru
prepar
made
yellow
fever
viru
strain
avail
provid
immun
year
effect
specif
antivir
therapi
yellow
fever
identifi
treatment
consist
provid
gener
support
care
vari
depend
organ
involv
yellow
fever
viru
kill
sodium
hypochlorit
glutaraldehyd
formaldehyd
ethanol
also
kill
heat
c
minut
tbe
human
viral
infecti
diseas
involv
predominantli
central
nervou
system
one
danger
human
infect
occur
europ
mani
part
asia
tbe
caus
member
tbe
viru
complex
flavivirida
tbe
viru
believ
caus
least
human
case
enceph
europ
annual
virus
within
group
includ
loup
ill
viru
langat
viru
powassan
viru
also
known
caus
human
enceph
rare
epidem
scale
transmiss
tbe
viru
spread
bite
tick
genu
ixod
spread
consumpt
contamin
raw
milk
tick
act
vector
reservoir
tbe
viru
small
rodent
main
host
human
accident
host
tbe
case
occur
period
highest
tick
activ
aprilnovemb
human
infect
rural
area
tick
bite
incub
period
day
patient
develop
typic
flulik
symptom
resolv
week
remiss
day
week
quarter
patient
develop
sever
symptom
includ
mening
meningoenceph
sever
case
quarter
case
partial
paralysi
may
seen
although
patient
recov
diseas
third
believ
longlast
neurolog
problem
includ
problem
cognit
balanc
coordin
diagnosi
base
confirm
exposur
tick
highrisk
area
tick
bite
within
previou
week
clinic
symptom
infect
cerebrospin
fluid
igm
igg
antibodi
serum
vaccin
kill
viru
avail
europ
specif
therapi
avail
support
care
use
treat
symptom
necessari
viru
kill
sodium
hypochlorit
glutaraldehyd
formaldehyd
ethanol
also
kill
heat
c
minut
tickborn
hemorrhag
fever
virus
includ
crimeancongo
hemorrhag
fever
cchf
omsk
hemorrhag
fever
kyasanur
forest
diseas
alkhurma
virus
cchf
viru
tickborn
viru
genu
nairoviru
within
famili
bunyavirida
diseas
first
character
crimea
later
recogn
caus
ill
congo
result
current
name
diseas
viru
widespread
found
africa
asia
middl
east
eastern
europ
nairoviru
genu
includ
member
transmit
argasid
ixodid
tick
implic
caus
human
diseas
dugb
nairobi
sheep
virus
cchf
import
human
pathogen
among
viru
transmit
bite
infect
adult
tick
genu
hyalomma
nosocomi
outbreak
also
occur
result
exposur
blood
secret
transmiss
also
occur
drink
raw
milk
slaughter
infect
anim
incub
period
day
record
longer
day
ill
begin
abruptli
high
fever
myalgia
headach
vomit
pain
epigastrium
lower
back
thigh
loos
stool
dri
cough
rel
bradycardia
may
present
day
hemorrhag
begin
seen
red
purpl
discolor
skin
develop
noseble
half
case
liver
enlarg
blood
found
saliva
urin
black
skin
patch
vomit
bleed
lead
shock
vascular
collaps
death
day
onset
symptom
fatal
rate
hospit
patient
rang
rapid
diagnosi
cchf
viru
made
classic
revers
transcriptas
rt
pcr
method
igg
igm
antibodi
detect
elisa
indirect
immunofluoresc
test
day
ill
vaccin
avail
cchf
intens
support
manag
requir
earli
stage
sometim
prolong
period
convalesc
often
slow
debil
last
week
recoveri
evid
cchf
respond
treatment
ribavirin
viru
kill
common
disinfect
dri
heat
c
minut
mdrtb
caus
mycobacterium
tuberculosi
resist
least
isoniazid
rifampicin
mdrtb
emerg
seriou
problem
mani
area
world
world
health
organ
estim
one
third
world
popul
infect
tuberculosi
mdrtb
preval
greater
among
new
tuberculosi
case
eastern
europ
latin
america
africa
asia
cdc
report
tuberculosi
case
unit
state
resist
isoniazid
wherea
resist
isoniazid
rifampicin
difficulti
treatment
abil
dissemin
aerosol
mdrtb
might
use
biolog
weapon
futur
earli
twentyfirst
centuri
advanc
technolog
one
may
think
major
infecti
diseas
threat
would
conquer
world
connect
massiv
easi
intern
travel
polit
trade
econom
cultur
make
possibl
potenti
global
spread
pathogen
microbi
world
previous
might
confin
remot
local
area
novel
infecti
diseas
agent
keep
get
discov
continu
emerg
reemerg
expand
geograph
rang
potenti
genet
manipul
bioweapon
pose
substanti
threat
throughout
world
infecti
diseas
present
signific
challeng
emerg
reemerg
threat
includ
sever
acut
respiratori
syndrom
sar
west
nile
viru
wnv
infect
pandem
influenza
monkey
poxviru
infect
histor
twentieth
centuri
saw
three
pandem
influenza
influenza
pandem
caus
least
us
death
million
death
worldwid
influenza
pandem
caus
least
us
death
million
death
worldwid
influenza
pandem
caus
us
death
death
worldwid
influenza
viru
respons
pandem
remain
uncertain
pandem
new
viru
contain
compon
previou
human
avian
influenza
virus
pandem
occur
mutant
influenza
viru
emerg
viru
exhibit
radic
chang
antigen
shift
chang
occur
continu
influenza
virus
antigen
drift
virul
pathogen
although
avian
influenza
virus
gener
replic
ineffici
human
subtyp
avian
influenza
replic
within
respiratori
tract
human
caus
diseas
sinc
highli
pathogen
strain
avian
influenza
spread
poultri
countri
asia
eastern
europ
consid
endem
countri
time
write
strain
caus
human
case
death
far
countri
includ
cambodia
china
indonesia
thailand
vietnam
concern
current
circul
strain
avian
influenza
evolv
pandem
strain
adapt
human
genet
mutat
reassort
human
influenza
strain
note
pig
trachea
contain
receptor
avian
human
influenza
virus
support
growth
virus
human
avian
origin
genet
reassort
human
avian
influenza
virus
may
occur
pig
lead
novel
strain
would
littl
popul
immun
would
highli
pathogen
capabl
humantohuman
transmiss
pandem
potenti
current
circul
strain
avian
influenza
also
potenti
bioterror
agent
aforement
properti
eas
propag
lack
vaccin
environment
stabil
viru
emerg
resist
antivir
agent
oseltamivir
human
influenza
infect
evid
consist
birdtohuman
possibl
environmenttohuman
transmiss
limit
nonsustain
humantohuman
transmiss
date
although
suggest
sever
household
cluster
appar
one
case
childtomoth
transmiss
viru
caus
avian
influenza
poultri
spread
human
result
contact
infect
poultri
airborn
spread
secret
contamin
food
prepar
undercook
poultri
also
implic
humantohuman
transmiss
influenza
viru
occur
inhal
infecti
droplet
droplet
nuclei
caus
cough
sneez
direct
contact
indirect
fomit
contact
incub
period
rang
day
median
day
initi
symptom
influenza
human
includ
fever
cough
sore
throat
muscl
ach
pneumonia
diarrhea
vomit
abdomin
pain
pleurit
pain
bleed
nose
gum
also
report
earli
cours
ill
progress
respiratori
failur
associ
acut
respiratori
distress
syndrom
complic
renal
dysfunct
cardiac
failur
multiorgan
failur
report
rapid
antigen
test
kit
differenti
variou
subtyp
influenza
viru
diagnosi
made
viru
isol
viral
cultur
detect
rna
rtpcr
earli
initi
antivir
agent
seem
benefici
avian
influenza
viru
suscept
vitro
neuraminidas
inhibitor
oseltamivir
zanamivir
oral
oseltamivir
inhal
zanamivir
activ
anim
model
inhal
zanamivir
studi
case
human
mechanist
neuraminidas
molecular
rearrang
occur
creat
pocket
oseltamivir
attach
viral
resist
oseltamivir
result
substitut
singl
amino
acid
result
mutat
mutat
caus
inhibit
neuraminidas
molecul
activ
site
chang
creat
pocket
oseltamivir
none
mutat
prevent
bind
zanamivir
viru
resist
zanamivir
yet
isol
case
report
neuraminidas
confer
highlevel
resist
oseltamivir
two
vietnames
patient
oseltamivir
treatment
present
licens
vaccin
avail
avian
influenza
human
sever
candid
vaccin
studi
chemoprophylaxi
mg
oseltamivir
mouth
everi
hour
prevent
day
recommend
individu
possibl
unprotect
exposur
household
contact
sar
respiratori
viral
ill
caus
newli
discov
coronaviru
sarsassoci
coronaviru
sarscov
sar
first
appear
southern
china
novemb
next
month
ill
spread
countri
north
america
south
america
europ
asia
recogn
global
threat
march
major
outbreak
contain
juli
recent
human
case
sar
report
china
april
outbreak
caus
laboratoryacquir
infect
time
write
known
sar
transmiss
world
sar
potenti
agent
bioterror
rapid
easi
transmiss
agent
respiratori
droplet
airborn
spread
short
incub
period
add
threat
sarscovlik
virus
isol
himalayan
palm
civet
raccoon
dog
anim
market
southern
china
suggest
sarscov
may
origin
wild
anim
consid
possibl
wild
anim
human
reservoir
sarscov
still
may
exist
concern
sar
may
return
sar
transmit
person
person
respiratori
droplet
airborn
spread
sarscov
isol
sputum
nasal
secret
serum
fece
bronchial
wash
specimen
howev
suggest
altern
mode
transmiss
may
exist
strict
adher
contact
droplet
precaut
ad
airborn
precaut
prevent
sar
transmiss
case
use
surgic
mask
significantli
reduc
transmiss
incub
period
typic
day
may
prolong
initi
symptom
includ
prodrom
fever
usual
accompani
dri
cough
headach
myalgia
nonspecif
symptom
usual
follow
develop
pneumonia
worsen
respiratori
symptom
diagnosi
sar
confirm
sarscovspecif
microbiolog
serolog
studi
includ
viral
cultur
rtpcr
clinic
specimen
antibodi
test
use
enzym
immunoassay
sensit
specif
test
yield
result
within
hour
need
especi
set
outbreak
realtim
nest
pcr
potenti
increas
sensit
earli
diagnosi
sar
sever
antivir
antiinflammatori
agent
evalu
treatment
sar
includ
ribavirin
oseltamivir
ritonavirlopinavir
interferon
alfa
corticosteroid
suffici
evid
recommend
specif
therapi
lack
mainstay
treatment
remain
support
care
wnv
singlestrand
rna
arboviru
famili
flavivirida
wnv
first
isol
uganda
subsequ
report
africa
europ
asia
israel
egypt
wnv
repres
potenti
effect
biolog
weapon
persist
anim
reservoir
season
predilect
rel
short
incub
period
broad
spectrum
clinic
ill
lack
vaccin
august
wnv
detect
first
time
north
america
caus
outbreak
new
york
citi
wnv
strain
unit
state
close
relat
genet
strain
israel
support
hypothesi
wnv
outbreak
unit
state
origin
introduct
strain
circul
israel
evid
howev
wnv
introduc
unit
state
deliber
possibl
viru
import
north
america
infect
bird
infect
mosquito
virem
human
wnv
season
epidem
unit
state
last
summer
fall
wnv
maintain
natur
cycl
involv
mosquito
bird
bird
usual
develop
high
level
prolong
viremia
serv
amplifi
host
human
hors
dog
serv
incident
host
human
wnv
infect
result
mosquito
bite
usual
culex
spp
infect
blood
product
transplant
organ
infect
donor
wnv
initi
replic
site
inocul
mosquito
bite
viru
may
infect
fibroblast
vascular
endotheli
cell
subsequ
spread
lymph
node
bloodstream
central
nervou
system
infect
may
occur
result
viremia
incub
period
infect
rang
day
may
prolong
human
infect
asymptomat
individu
symptom
develop
present
selflimit
febril
ill
character
fever
headach
fatigu
malais
myalgia
gastrointestin
symptom
neuroinvas
diseas
occur
less
infect
patient
mening
enceph
complic
acut
asymmetr
flaccid
paralysi
paralysi
also
occur
without
overt
mening
enceph
howev
flaccid
paralysi
result
involv
anterior
horn
cell
wnv
similar
seen
poliomyel
commonli
use
method
diagnosi
detect
igm
antibodi
wnv
serum
cerebrospin
fluid
provid
strong
evid
recent
wnv
infect
wnv
also
detect
cerebrospin
fluid
blood
tissu
isol
nucleic
acid
amplif
test
rtpcr
nucleic
acid
sequencebas
amplif
techniqu
sensit
cultur
detect
wnv
infect
treatment
mainli
support
care
trial
interferon
alfa
intraven
immunoglobulin
treatment
wnv
infect
current
ongo
current
human
vaccin
avail
wnv
infect
human
monkeypox
caus
monkeypox
viru
member
famili
poxvirida
genu
orthopoxviru
import
virus
group
includ
variola
viru
viru
caus
smallpox
vaccinia
viru
viru
use
smallpox
vaccin
first
human
case
monkeypox
report
democrat
republ
congo
formerli
republ
zair
sinc
diseas
endem
congo
basin
countri
africa
sinc
discontinu
routin
smallpox
vaccin
result
lack
immun
popul
concern
potenti
use
monkeypox
viru
bioterror
agent
risk
also
includ
recombin
variou
pox
virus
genet
engin
manipul
monkeypox
viru
exhibit
greater
virul
transmiss
monkeypox
viru
emerg
first
time
western
hemispher
outbreak
human
monkeypox
occur
midwestern
unit
state
patient
got
sick
direct
contact
pet
prairi
dog
becam
infect
hous
rodent
import
ghana
western
africa
contrast
african
patient
us
patient
mild
selflimit
ill
monkeypox
transmit
human
direct
contact
handl
infect
anim
humantohuman
transmiss
occur
larg
respiratori
droplet
prolong
facetofac
contact
touch
bodi
fluid
sick
person
incub
period
day
prodrom
symptom
includ
fever
malais
lymphadenopathi
clinic
featur
human
monkeypox
diseas
resembl
ordinari
smallpox
lymphadenopathi
consid
distinguish
featur
human
monkeypox
rash
distribut
mainli
trunk
spread
peripher
fashion
toward
palm
sole
clinic
cours
complic
secondari
skin
soft
tissu
infect
pneumon
enceph
ocular
complic
variou
laboratori
test
diagnosi
monkeypox
viru
includ
pcr
electron
microscopi
igm
igg
elisa
immunofluoresc
antibodi
assay
histopatholog
mani
test
differenti
differ
orthopoxvirus
viru
isol
use
cell
cultur
chick
chorioallanto
membran
conjunct
dnabas
assay
consid
definit
test
identif
monkeypox
viru
cidofovir
broadspectrum
antivir
drug
vitro
activ
monkeypox
viru
rel
toxic
consid
sever
case
human
monkeypox
viru
infect
data
current
avail
effect
vaccinia
immunoglobulin
treat
human
monkeypox
viru
infect
complic
vaccin
vaccinia
viru
protect
infect
monkeypox
viru
biolog
threat
categor
convent
genet
modifi
agent
tradit
biolog
weapon
includ
natur
occur
organ
toxin
character
eas
product
toxic
stabil
mode
transmiss
danger
associ
convent
agent
enhanc
genet
modif
exampl
potenti
genet
modif
includ
increas
virul
antibiot
resist
toxin
product
enhanc
aerosol
stabil
improv
surviv
biolog
agent
continu
develop
advanc
biotechnolog
tremend
potenti
revolution
present
futur
biolog
threat
facilit
entir
new
class
fulli
engin
agent
refer
advanc
biolog
warfar
agent
advanc
biolog
warfar
agent
specif
engin
target
specif
organ
system
eg
cardiovascular
gastrointestin
neurolog
specif
biolog
process
eg
incapacit
neurolog
impair
death
threat
use
weapon
form
certain
biolog
agent
civilian
popul
bioterror
attack
emerg
past
year
advanc
biotechnolog
categori
c
bioterror
agent
emerg
pathogen
may
becom
attract
weapon
bioterrorist
bioterrorist
categori
c
bioterror
agent
emerg
pathogen
mani
advantag
convent
weapon
biolog
agent
list
categori
b
includ
rel
low
cost
rel
access
rel
eas
could
produc
deliv
avoid
detect
use
even
threaten
use
potenti
capabl
produc
widespread
social
disrupt
although
biotechnolog
tool
bioterrorist
could
develop
weapon
mass
destruct
also
use
improv
method
fight
weapon
